Mederma to Reduce Appearance of Post Surgical Scars

Merz Pharmaceuticals

Status

Completed

Conditions

Scars

Treatments

Other: Mederma Ultra Gel

Other: Mederma N&I

Study type

Interventional

Funder types

Industry

Identifiers

NCT01504061

MUS90025-4007-0

Details and patient eligibility

About

This is a single-center, 20-subject, investigator-blinded study to evaluate the effect of Mederma N&I to Mederma Ultra Gel on the appearance of post-surgical scars.

Full description

This is a 10-week research study designed to compare the effect of two gels on the appearance of post surgical scarring of the chest and/or back. The subject will be asked to identify two symmetrical skin growths that they would like to have removed: one on the left chest and/or back and one on the right chest and/or back. Additionally, the subject will identify a third skin growth that they would like removed which is a reasonable distance from the two symmetrical skin growths and will be located either on the back or the chest.

Inclusion Criteria:

Healthy male and non pregnant female subjects ≥18 years of age
have seborrheic keratoses on the right and left chest and/or back

Exclusion Criteria:

-Subjects with known allergies or sensitivities to ingredients contained in the test product including onion extract and Lidocaine.

Enrollment

20 patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Subjects must be 18-70 years of age, of any race or sex.
Subjects must be Fitzpatrick skin type I-VI.
Subjects must have two symmetrical upper chest and/or back seborrheic keratoses and in the opinion of the investigator are good candidates for the study.

Exclusion criteria

Subjects with known allergies or sensitivities to ingredients contained in the test product including onion extract and Lidocaine.
Subjects with known history of keloids or hypertrophic scars.